Navigation Links
Advanced Prostate Cancer Patients Finally Have Another Option
Date:4/29/2010

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration (FDA).

Men's Health Network (MHN) is excited to see this innovative treatment option made available for patients with asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone refractory) prostate cancer. Provenge harnesses the individual's own immune system to fight cancer through a process called active cellular immunotherapy.

Provenge offers hope for men (and their families) to potentially extend and improve the quality of life for those who are suffering from advanced prostate cancer.  Patients should work with their healthcare providers to determine if they are an appropriate candidate for Provenge at this time.

There is an immense need for more options and awareness about the plight of men with advanced prostate cancer. MHN is very excited that the approval of Provenge brings us one step closer to this goal by adding a breakthrough treatment option for these men.  Men now have an opportunity to engage in a conversation with their health care provider about this new innovative immunotherapy to potentially extend and improve their quality of life.

For more information about prostate cancer, please visit www.menshealthnetwork.org or call us at 866-543-6461, extension 101.

About Men's Health Network

Men's Health Network (www.menshealthnetwork.org) is a national non-profit organization whose mission is to reach men and their families where they live, work, play, and pray with health prevention messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation.


'/>"/>
SOURCE Men's Health Network
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
2. The Wellcore System Begins Shipping Featuring the Most Advanced Automatic Fall Detection Available
3. MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation
4. Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinsons Disease
5. VIDEO from Medialink and LSI: Advanced Technologies Make Science More Accessible
6. Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer
7. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
8. Advanced Life Sciences Announces 2009 Fourth Quarter and Full Year Financial Results
9. Advanced Life Sciences to Host 2009 Fourth Quarter and Full Year Financial Results Conference Call and Webcast
10. UAB Hospital to Integrate Advanced Symbiq(TM) Infusion Device With EHR to Enhance Safety and Clinician Workflow
11. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 23, 2017 Endo International plc (NASDAQ / ... today filed a joint motion in the U.S. District ... seeking the entry of a ten-year Stipulated ... disputes between the FTC and Endo relating to the ... its Opana® ER and Lidoderm® products.  It also resolves ...
(Date:1/23/2017)... -- Consolidated Stability Storage is Leading to CROs Evolving ... Market This research service on the global pharmaceutical ... technologies, and provides a snapshot of the key participants ... forecasts are provided from 2016 to 2020. ... of 9.4% till 2020, driven by an explosion of ...
(Date:1/23/2017)... Research and Markets has announced the addition of the ... to their offering. ... The interventional radiology products market is expected to reach USD ... a CAGR of 4.8%. This market is segmented based on type, ... growth of this market are rising incidence of chronic diseases, rising ...
Breaking Medicine Technology:
(Date:1/23/2017)... ARLINGTON, VA (PRWEB) , ... ... ... Seafood Nutrition Partnership (SNP) has launched online education programs and resources at ... health and nutritional benefits of a seafood-rich diet. These resources have been ...
(Date:1/23/2017)... ... ... time when many people celebrate romance and love by giving cards, candy, flowers or other ... Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s Day special: Spend $100 on ... free. , “A lot of people just buy the more predictable gift of flowers ...
(Date:1/22/2017)... ... 2017 , ... "Photo Cloud allows FCPX users to add favorited photos to ... ease," said Christina Austin - CEO of Pixel Film Studios. , To begin, ... timeline. Presets include scenes with one, three, four or five focus points. There are ...
(Date:1/21/2017)... , ... January 21, 2017 , ... Salveo for life, ... is bringing its product to the United States as part of its presence to ... 25 years, Alcovit aims to reduce the productions of nasty toxins as a result ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to take an ... of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, a ... Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel to cleanse ...
Breaking Medicine News(10 mins):